Dendritic cells: A new horizon in cell therapy for inflammatory bowel disease?;Células dendríticas: ¿un nuevo horizonte en la terapia celular de la enfermedad inflamatoria intestinal?

Gastroenterologia y Hepatologia

Volumn 34, Issue 2, 2011, Pages 100-106

  Ricart, Elena ^a   Panés, Julián ^a   Benítez Ribas, Daniel ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Autoimmune diseases; Crohn's disease; Dendritic cells; Inflammatory bowel disease; Tolerance

Indexed keywords

ARTICLE; AUTOIMMUNE DISEASE; CELL THERAPY; CROHN DISEASE; DENDRITIC CELL; ENTERITIS; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE;

CROHN DISEASE; DENDRITIC CELLS; HUMANS; INFLAMMATORY BOWEL DISEASES;

EID: 79952068767     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2010.10.011     Document Type: Article

References (33)

1. Schuler G. Dendritic cells in cancer immunotherapy. Eur J Immunol.2010;40:2123-30.
2. Guilliams M., Henri S., Tamoutounour S., Ardouin L., Schwartz-Cornil I., Dalod M., et al. From skin dendritic cells to a simplified classification of human and mouse dendritic cell subsets. Eur J Immunol. 2010, 40:2089-2094.
3. Dzionek A., Fuchs A., Schmidt P., Cremer S., Zysk M., Miltenyi S., et al. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol. 2000, 165:6037-6046.
4. Iwasaki A., Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol. 2004, 5:987-995.
5. Kadowaki N., Ho S., Antonenko S., Malefyt R.W., Kastelein R.A., Bazan F., et al. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med. 2001, 194:863-869.
6. Poulin L.F., Salio M., Griessinger E., Anjos-Afonso F., Craciun L., Chen J.L., et al. Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells. J Exp Med. 2010, 207:1261-1271.
7. Holtl L., Rieser C., Papesh C., Ramoner R., Herold M., Klocker H., et al. Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells. J Urol. 1999, 161:777-782.
8. Figdor C.G., de Vries I.J., Lesterhuis W.J., Melief C.J. Dendritic cell immunotherapy: mapping the way. Nat Med. 2004, 10:475-480.
9. Veny M., Esteller M., Ricart E., Piqué J.M., Panés J., Salas A. Late Crohn's disease patients present an increase in peripheral Th17 cells and cytokine production compared with early patients. Aliment Pharmacol Ther. 2010, 31:561-572.
10. Dhodapkar M.V., Steinman R.M., Krasovsky J., Munz C., Bhardwaj N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med. 2001, 193:233-238.
11. Emmer P.M., van der Vlag J., Adema G.J., Hilbrands L.B. Dendritic cells activated by lipopolysaccharide after dexamethasone treatment induce donor-specific allograft hyporesponsiveness. Transplantation. 2006, 81:1451-1459.
12. Iliev I.D., Mileti E., Matteoli G., Chieppa M., Rescigno M. Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning. Mucosal Immunol. 2009, 2:340-350.
13. Piemonti L., Monti P., Allavena P., Sironi M., Soldini L., Leone B.E., et al. Glucocorticoids affect human dendritic cell differentiation and maturation. J Immunol. 1999, 162:6473-6481.
14. Penna G., Adorini L. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol. 2000, 164:2405-2411.
15. Lagaraine C., Lemoine R., Baron C., Nivet H., Velge-Roussel F., Lebranchu Y. Induction of human CD4+ regulatory T cells by mycophenolic acid-treated dendritic cells. J Leukoc Biol. 2008, 84:1057-1064.
16. Gonzalez-Rey E., Delgado M. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide. Gastroenterology. 2006, 131:1799-1811.
17. Allavena P., Piemonti L., Longoni D., Bernasconi S., Stoppacciaro A., Ruco L., et al. IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. Eur J Immunol. 1998, 28:359-369.
18. de Vries I.J., Eggert A.A., Scharenborg N.M., Vissers J.L., Lesterhuis W.J., Boerman O.C., et al. Phenotypical and functional characterization of clinical grade dendritic cells. J Immunother. 2002, 25:429-438.
19. Chamorro S., Garcia-Vallejo J.J., Unger W.W., Fernandes R.J., Bruijns S.C., Laban S., et al. TLR triggering on tolerogenic dendritic cells results in TLR2 up-regulation and a reduced proinflammatory immune program. J Immunol. 2009, 183:2984-2994.
20. Banchereau J., Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity. 2006, 25:383-392.
21. Lowes M.A., Chamian F., Abello M.V., Fuentes-Duculan J., Lin S.L., Nussbaum R., et al. Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc Natl Acad Sci U S A. 2005, 102:19057-19062.
22. Asselin-Paturel C., Trinchieri G. Production of type I interferons: plasmacytoid dendritic cells and beyond. J Exp Med. 2005, 202:461-465.
23. Hue S., Ahern P., Buonocore S., Kullberg M.C., Cua D.J., McKenzie B.S., et al. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med. 2006, 203:2473-2483.
24. Aldinucci A., Biagioli T., Manuelli C., Repice A.M., Massacesi L., Ballerini C. Modulating dendritic cells (DC) from immunogenic to tolerogenic responses: a novel mechanism of AZA/6-MP. J Neuroimmunol. 2010, 218:28-35.
25. Tarbell K.V., Petit L., Zuo X., Toy P., Luo X., Mqadmi A., et al. Dendritic cell, expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice. J Exp Med. 2007, 204:191-201.
26. Dittel B.N., Visintin I., Merchant R.M., Janeway C.A. Presentation of the self antigen myelin basic protein by dendritic cells leads to experimental autoimmune encephalomyelitis. J Immunol. 1999, 163:32-39.
27. Tang J., Zhu W., Silver P.B., Su S.-B., Chan C.-C., Caspi R.R. Autoimmune uveitis elicited with antigen-pulsed dendritic cells has a distinct clinical signature and is driven by unique effector mechanisms: initial encounter with autoantigen defines disease phenotype. J Immunol. 2007, 178:5578-5587.
28. Tamaki S., Homma S., Enomoto Y., Komita H., Zeniya M., Ohno T., et al. Autoimmune hepatic inflammation by vaccination of mice with dendritic cells loaded with well-differentiated hepatocellular carcinoma cells and administration of interleukin-12. Clin Immunol. 2005, 117:280-293.
29. Ludewig B., Odermatt B., Landmann S., Hengartner H., Zinkernagel R.M. Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue. J Exp Med. 1998, 188:1493-1501.
30. Shoenfeld Y., Blank M., Abu-Shakra M., Amital H., Barzilai O., Berkun Y., et al. The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases. Isr Med Assoc J. 2008, 10:13-19.
31. Shoenfeld Y., Zandman-Goddard G., Stojanovich L., Cutolo M., Amital H., Levy Y., et al. The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases. Isr Med Assoc J. 2008, 10:8-12.
32. Shoenfeld Y., Gilburd B., Abu-Shakra M., Amital H., Barzilai O., Berkun Y., et al. The mosaic of autoimmunity: genetic factors involved in autoimmune diseases. Isr Med Assoc J. 2008, 10:3-7.
33. Stoop J.N., Harry R.A., von Delwig A., Isaacs J.D., Robinson J.H., Hilkens C.M. Therapeutic effect of tolerogenic dendritic cells in established collagen-induced arthritis is associated with a reduction in Th17 responses. Arthritis Rheum. 2010;40:2123-30.